Exclusive Webinar :Don't miss the latest webinar on Global Investing with Passive Products on June 22, 11am
you are here: HomeNewsTrends

COVID-19 | Vaccine stock for 18-44 age group in Delhi to last for only three days: Manish Sisodia

Manish Sisodia, quoting a letter which he claimed to have received from the Centre, said Delhi would get 3,83,000 doses only for the 45-plus group in May.

May 17, 2021 / 07:16 PM IST
Delhi Deputy CM Manish Sisodia (File image)

Delhi Deputy CM Manish Sisodia (File image)

The vaccine stock for 18-44 age group in Delhi will last for only three days, Deputy Chief Minister Manish Sisodia said on May 17. The Centre has refused to provide more doses to inoculate the non-priority group in May, Sisodia claimed in a press briefing.

The vaccine stock for the priority group, that is for those aged above 45, will last for four days, he added. The central government, however, would provide more doses to continue the inoculation drive for the 45-plus group.

Sisodia, quoting a letter which he claimed to have received from the Centre, said that Delhi would get 3,83,000 doses for the 45-plus group in May. However, no jabs would be provided for this month for the 18-44 group, he said.

Also Read | Too early to say 2nd wave has peaked; vaccine availability national bottleneck: CRISIL

Sisodia has sought 3.82 lakh more vaccine doses to continue the inoculation drive for the 18-44 age group in May. He said that he has written another letter to the Centre to reiterate his request for more vaccine supplies.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"We need more vaccines for the 18-44 age group. We are ready to buy those but at least make those available. We will have to close the vaccination centres for the 18-44 age group after three days," he said.

Sisodia further urged the Centre to make the data on vaccine allocation to the states public.

"There should be transparency in the data. For Delhi, we need to know how much is being given to the government and how much to the private sector and even for other states, we need to know the figures," he said.

"Please let us know about the vaccine availability for the next two months so that we can chalk out the vaccination programme for June and July," the deputy chief minister added.

With PTI inputs.
Moneycontrol News

stay updated

Get Daily News on your Browser